Unknown

Dataset Information

0

Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapy.


ABSTRACT: Gene therapy is a promising emerging therapeutic modality for the treatment of cardiovascular diseases and hereditary diseases that afflict the heart. Hence, there is a need to develop robust cardiac-specific expression modules that allow for stable expression of the gene of interest in cardiomyocytes. We therefore explored a new approach based on a genome-wide bioinformatics strategy that revealed novel cardiac-specific cis-acting regulatory modules (CS-CRMs). These transcriptional modules contained evolutionary-conserved clusters of putative transcription factor binding sites that correspond to a "molecular signature" associated with robust gene expression in the heart. We then validated these CS-CRMs in vivo using an adeno-associated viral vector serotype 9 that drives a reporter gene from a quintessential cardiac-specific ?-myosin heavy chain promoter. Most de novo designed CS-CRMs resulted in a >10-fold increase in cardiac gene expression. The most robust CRMs enhanced cardiac-specific transcription 70- to 100-fold. Expression was sustained and restricted to cardiomyocytes. We then combined the most potent CS-CRM4 with a synthetic heart and muscle-specific promoter (SPc5-12) and obtained a significant 20-fold increase in cardiac gene expression compared to the cytomegalovirus promoter. This study underscores the potential of rational vector design to improve the robustness of cardiac gene therapy.

SUBMITTER: Rincon MY 

PROVIDER: S-EPMC4426801 | biostudies-other | 2015 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapy.

Rincon Melvin Y MY   Sarcar Shilpita S   Danso-Abeam Dina D   Keyaerts Marleen M   Matrai Janka J   Samara-Kuko Ermira E   Acosta-Sanchez Abel A   Athanasopoulos Takis T   Dickson George G   Lahoutte Tony T   De Bleser Pieter P   VandenDriessche Thierry T   Chuah Marinee K MK  

Molecular therapy : the journal of the American Society of Gene Therapy 20140908 1


Gene therapy is a promising emerging therapeutic modality for the treatment of cardiovascular diseases and hereditary diseases that afflict the heart. Hence, there is a need to develop robust cardiac-specific expression modules that allow for stable expression of the gene of interest in cardiomyocytes. We therefore explored a new approach based on a genome-wide bioinformatics strategy that revealed novel cardiac-specific cis-acting regulatory modules (CS-CRMs). These transcriptional modules cont  ...[more]

Similar Datasets

| S-EPMC2395258 | biostudies-literature
| S-EPMC4761415 | biostudies-other
| S-EPMC2174486 | biostudies-literature
| S-EPMC2930411 | biostudies-literature
| S-EPMC1291357 | biostudies-literature
| S-EPMC2605473 | biostudies-literature
| S-EPMC7296022 | biostudies-literature
| S-EPMC3202680 | biostudies-literature
| S-EPMC3074163 | biostudies-literature
| S-EPMC6918188 | biostudies-literature